| Literature DB >> 24980108 |
Femke van Wijk1, Stefan Nierkens2.
Abstract
With the growing understanding that drugs might induce immune-mediated adverse reactions in patients, immunotoxicity testing of new pharmaceuticals has become an important topic in drug development. The nonclinical assessment of unexpected immune suppression is based on relatively well-standardized and validated assays and animal models. For the evaluation of direct immune stimulation few animal models are available, whilst the development of animal models to assess drug-induced hypersensitivity and in particular autoimmunity is in its infancy.: � 2006 Elsevier Ltd . All rights reserved.Entities:
Year: 2006 PMID: 24980108 DOI: 10.1016/j.ddtec.2006.03.003
Source DB: PubMed Journal: Drug Discov Today Technol ISSN: 1740-6749